Factor VIII Plasma-derived 500IU HemoRel A
Indian Council of Medical Research (ICMR) · Mumbai, Maharashtra · Healthcare Services · open
Key facts
- Closing date: 31 Jul 2026
- Status: open
- Ministry: Ministry of Health and Family Welfare
- Department: Department of Health Research
- Office: Mumbai
Description
Tender for supply of Factor VIII Plasma-derived 500IU HemoRel A, Reliance Lifesciences, with a total quantity of 10 units, issued by Indian Council of Medical Research (ICMR) under the Department of Health Research, Ministry of Health and Family Welfare. The bid is valid for 180 days from the end date, with a bid opening scheduled on 31-07-2026 at 09:30 AM. The tender includes specifications, delivery, and compliance details, with provisions for MSE and startup preferences.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: Yes
- Documents required: Udyam Certificate, Bidder credentials validation
Commercial terms
- Bid type: Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- Factor VIII Plasma-derived 500IU HemoRel A — Qty: 10 unit
1 tender document(s) available — sign up to download.